-Member Login

Forgot your USERNAME OR PASSWORD?

Job Postings

Let's Stay Connected

Find us on the popular social networks

Facebook Twitter LinkedIn Flicker

Journal Highlights

MOL Highlight: Ability of Bruton’s Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency

Posted on 2/23/2017 4:13:57 PM

MOL Feb Highlights Bender et al 

Bruton’s tyrosine kinase (Btk) regulates signaling downstream of the B-cell receptor (BCR) and Fc receptors (FcRs). Consequently, inhibitors targeting the kinase have the potential to simultaneously block multiple disease pathways in hematopoietic cells. Here, Bender et al. characterize nine different Btk·inhibitor complexes, and show that these compounds can be classified by their ability to trigger sequestration of Btk residue Y551, which renders it inaccessible for phosphorylation. The ability to sequester Y551 was an important determinant of potency against FcR signaling, but less critical for potency against BCR signaling. The results thus delineate molecular determinants that dictate the selective effects of different classes of Btk inhibitors, and provide insight into the design new compounds with a broader inhibitory profiles that will hopefully have greater efficacy in treating disease.

See the article by Bender et al. at Molecular Pharmacology March 2017, 91 (3) 208-219; DOI: https://doi.org/10.1124/mol.116.107037 

Comments (0)


Leave a comment


Blog comments are moderated and will be posted once approved.

Name


Comment:


Enter the code shown below:

Recent Posts

Archive

.

Hot Links 

EB2017 

Join ASPET 

What is Pharmacology? Video 

PharmTalk Blog